The results showed that only SETD2 mutations were associated with ccRCC progression (Figures 2A, B; S2A), implying that most driver mutations may be closely associated with tumorigenesis rather than ccRCC progression. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.